The normal gastric mucosa contains mucus-secreting cells in the cardia, acid-producing and pepsin-producing cells in the fundus and body, and hormone-producing cells in the pylorus. The stomach functions to mix and start digestion of food, activate enzymes, destroy bacteria, and absorb nutrients, alcohol, water, and vitamins. Common pathologies of the stomach include peptic ulcers, gastritis, tumors, and congenital anomalies like pyloric stenosis. Chronic gastritis is often caused by H. pylori infection and can lead to atrophy, intestinal metaplasia, and increased cancer risk over time if not treated.
IT INCLUDES ANATOMY, PHYSIOLOGY AND PATHOLOGY OF LIVER .
THE SOURCES ARE:-
THE MEDICAL TEXT BOOK OF ROBBIN'S PATHOLOGY
AND OTHERS
IMAGES SOURCE :- ATLAS BOOKS AND INTERNET
IT INCLUDES ANATOMY, PHYSIOLOGY AND PATHOLOGY OF LIVER .
THE SOURCES ARE:-
THE MEDICAL TEXT BOOK OF ROBBIN'S PATHOLOGY
AND OTHERS
IMAGES SOURCE :- ATLAS BOOKS AND INTERNET
Gastric Cancer - Deifinition , epidemiology , histological types and molecular genetics and WHO update
Reference - WHO Classificiation of tumors of Digestive system
Rosai and Ackermann
Gastric Cancer - Deifinition , epidemiology , histological types and molecular genetics and WHO update
Reference - WHO Classificiation of tumors of Digestive system
Rosai and Ackermann
A localized loss of gastric as well as duodenal mucosa leads to the formation of peptic ulcer.
A peptic ulcer is a sore on the lining of your stomach, small intestine or esophagus. A peptic ulcer in the stomach is called a gastric ulcer. A duodenal ulcer is a peptic ulcer that develops in the first part of the small intestine (duodenum). An esophageal ulcer occurs in the lower part of your esophagus.
Peptic ulcer arises when the normal mucosal defense mechanisms (mucus blood flow formation of HCO3- PGE2 ) are impaired or overpowered by damaging factors (acids pepsin pylori)
Ulcers occur 5 times more commonly in the duodenum and 95% of them are found in pyloric channel
The word Gastritis comes from two words “gastro” referring to the stomach and “itis” means inflammation.
Gastritis is an inflammation, irritation, or erosion of the lining of the stomach mucosa.
Inflammation of the lining of the stomach.
INCIDENCE:
The incidence of gastritis is highest in the fifth and sixth decades of life; men are more frequently affected than women. The incidence is greater in clients who are heavy drinkers and smokers.
Acute gastritis is considered one of the most common type of gastritis. This is a painful inflammation of the lining of the stomach that occur suddenly and may involve bleeding of the stomach mucosa
Chronic gastritis involve s long- term inflammation of the mucosal lining of the stomach and this inflammatory condition of upper digestive system can last for years.
Chronic gastritis, on the other hand, is more often found in older people
I am a professional pharmacist. These slides provide for pharmacy department students. These slides describe pathology some topics.
Such as peptic ulcer disease, Immunity etc.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
8. Stomach
Functions
◦ Mix food
◦ Reservoir
◦ Start digestion of
Protein
Nucleic acids
Fats
◦ Activates some enzymes
◦ Destroy some bacteria
◦ Makes intrinsic factor –
B 12 absorption
◦ Destroys some bacteria
◦ Absorbs
Alcohol
Water
Lipophilic acid
B 12
8
9. Bezoar
A bezoar is a mass found trapped in
the gastrointestinal system (usually
the stomach), though it can occur in
other locations.
A pseudobezoar is an indigestible
object introduced intentionally into the
digestive system.
There are several varieties of bezoar,
some of which have inorganic
constituents and others organic.
11. Pyloric stenosis
In 95% of infants with pyloric stenosis
the age at presentation is between 3
and 12 weeks of life, typically between
3 and 8 weeks.
Pyloric stenosis has been reported in
neonates within the first day of life.
11
13. etiology
3 in 1,000 live births
more commonly in males
30 percent of cases occur in firstborn
genetic predisposition
Sibling has 5 times more incidence
environmental factors
Neonatal hypergastrinemia and gastric
hyperacidity may have a role
13
14. CLINICAL MANIFESTATIONS
The classic presentation of IHPS
is the three- to six-week-old baby
who develops immediate
postprandial, non-bilious, often
projectile VOMITING and
demands to be re-fed soon
afterwards
(a "hungry vomiter").
14
15. Palpable mass
The mass is most easily felt
immediately after emesis because it
may otherwise be obscured by a
distended antrum and/or tensed
abdominal muscles
15
16. Pancreatic heterotopia
Pancreatic tissue outside boundaries
of pancreas without anatomic or
vascular connections to pancreas
● Also called ectopic pancreas
● Present in 0.5% to 14% of autopsies
● Due to displacement of pancreatic
tissue during embryonic development
16
21. Pathophysiology
The mechanisms of mucosal injury in gastritis is thought
to be an imbalance of
aggressive factors
acid production or pepsin
and
defensive factors
mucus production
bicarbonate
and blood flow
21
24. Classification of gastritis
Acute Chronic
•H pylori gastritis
•Other infective gastritis – bacteria,
virus, fungi, parasite
•Acute non infective gastritis
•Type A- autoimmune
•Type B- h pylori related
•Type AB- environmental
•Chemical – reflux gastritis
•Uncommon forms
24
25. Acute & Chronic Difference
◦ Acute refers to short term inflammation
◦ Acute refering to neurophilic infiltrate
◦ Chronic referring to long standing forms
◦ Chronic referring to mononuclear cell
infiltrate especially lymphocyte and
macrophages
25
26. Acute Gastritis
Definition
◦ An acute mucosal inflammatory
process, with neutrophilic infiltrate,
that is usually transient.
◦ There may be hemorrhage into the
mucosa or sloughing of the mucosa.
◦ Severe erosive form is an important
cause of severe GI bleeding
26
27. Etiology
◦ Frequently associated with, among others:
heavy use of NSAIDS, especially aspirin
excessive alcohol consumption
heavy smoking
severe stress e.g. trauma, burns, surgery
Ischemia
Systemic infection
◦ Often, idiopathic
27
28. NSAIDs
NSAIDs and aspirin also
interfere with the protective
mucus layer by inhibiting
mucosal cyclooxygenase
activity, reducing levels of
mucosal prostaglandins
28
29. Smoking
Promotes gastritis & ulcer occurrence
Increases the likelihood of
ulcer complications
Mechanisms
◦ Stimulate gastric acid secretion
◦ Stimulate bile salt reflux
◦ Causes alteration in mucosal blood flow
◦ Decrease mucus secretion
◦ Reduces prostaglandin synthesis
◦ Decrease pancreatic bicarbonate secretion
29
30. Acute Gastritis - Pathogenesis
30
All above Factor Acid secretion
+ back diffusion
+ Bicarbonate
buffer
+
Blood flow
Disruption
of
Mucus layer
+
Direct
Mucosal
Injury
Acute Gastritis
31. Stages of Acute Gastritis
Acute superficial
gastritis
Inflammation of
superficial
gastric mucosa.
Acute erosive
gastritis
Destruction of
multiple small
zones of superficial
mucosa.
Acute Gastric Ulceration
Destruction of full thickness of mucosa
31
33. Acute Gastritis - Morphology
Ranges from edema with neutrophil infiltration, vascular congestion,&
an intact epithelium, to erosion (mucosal defect that does not cross
the muscularis mucosa) and hemorrhage.
33
38. Chronic Gastritis
Definition
◦ Chronic mucosal inflammatory changes
leading to atrophy and metaplasia
(usually without erosions)
Dysplasia and ultimate neoplasia are
complications.
38
46. Pathogenetic qualities of H.pylori;
Adheres to gastric epithelium
Lives within mucous gel layer overlying gastric epithelium
Penetrates intercellular junctions
Invades gastric glands and canaliculi of parietal cells
Secretes urease to produce ammonia, which protects it from
gastric acid
Produces cytotoxins that may play role in pathogenicity
Induces epithelial cytolysis and disrupts intercellular
junctions
Increases permeability of mucous layer to hydrogen ions
and pepsin
Enables gastric acid and pepsin to create ulcer craters
Evades host immune defenses
Damages tissue.
46
50. Helicobacter gastritis
2 patterns of infection
◦ Diffuse involvement of body and antrum
(“pan gastritis” associated with
diminishing acid output)
◦ Infection confined to antrum (antral
gastritis, associate with increased acid
output)
50
51. Type A (Auto immune)
Etiology
◦ Autoimmune - antibodies to parietal cells,
gastrin receptor, intrinsic factor, and H+,K+
ATPase
<10% of cases of chronic gastritis
Possible autosomal dominant inheritance
51
52. Morphology of chronic gastritis
Chronic inflammatory cell
infiltration
Mucosal atrophy
Intestinal (goblet cell)
metaplasia
Seen in Helicobacter and
autoimmune gastritis (not
chemical)
52
53. Autoimmune gastritis
Autoimmune gastritis -
pernicious anemia
Chronic atrophic
gastritis is associated
with Ab’s
- intrinsic factor
- patietal cell
bright green IF- in the
parietal cells of the
gastric mucosa.
53
55. Chronic Gastritis
Clinical Features
◦ Usually only a few symptoms: nausea,
vomiting, upper abdominal discomfort
◦ Autoimmune
Hypo to achlorhydria (severe loss of
parietal glands)
Hypergastrinemia
10% have pernicious anemia
55
56. Clinical Complications
◦ Autoimmune:
Often seen in association with other
autoimmune disorders (Hashimoto
thyroiditis, Addison disease, and type I
diabetes)
Significant risk for the development of
gastric carcinoma (2-4%) and
endocrine tumors (carcinoid tumor)
56
57. Chronic Gastritis
Morphology
◦ Varying degrees of mucosal damage
possible
◦ Mucosal lesions are reddened, with
thickened rugae
◦ Atrophied rugae in long-standing cases
◦ Lymphocytes and plasma cell infiltrate;
neutrophils indicate “active” inflammation
(may or may not be present)
57
58. ◦ Regeneration - constant feature
◦ Metaplasia - mucosa of antral and
body-fundic regions converts to
columnar absorptive cells and goblet
cells (intestinal metaplasia)
◦ Atrophy - marked loss of glands
◦ Dysplasia – precursor lesion to gastric
cancer in atrophic gastritis
58
59. Sydney System of
Grading Chronic Gastritis
1. Site: Antral, Corporal mucosa
2. Grading of: (Mild, Moderate, Marked)
H-Pylori
Chronic inflammation
Activity
Atrophy
Intestinal metaplasia
*Normal lymphocytes & plasma cells in lamina propria = up to
5/HPF
*No Neutrophils in lamina propria
61. Peptic Ulcer Disease
Condition characterized by
◦ Erosion of GI mucosa resulting from
digestive action of HCl and pepsin
62. Peptic Ulcer Disease
Ulcer development
◦ Lower esophagus
◦ Stomach
◦ Duodenum
◦ 10% of men, 4% of women
63. Types
Acute
◦ Superficial erosion
◦ Minimal erosion
Chronic
◦ Muscular wall erosion with formation of
fibrous tissue
◦ Present continuously for many months or
intermittently
64. Peptic Ulcer Disease
Etiology and Pathophysiology
Develop only in presence of acid
environment
Excess of gastric acid not necessary
for ulcer development
Person with a gastric ulcer has normal
to less than normal gastric acidity
compared with person with a duodenal
ulcer
65. Peptic Ulcer
Size – variable; 0.3 – 4 cm in
diameter
Shape - round to oval
Sharply demarcated, clean-cut,
punched-out area with clean base
Margins are usually level with
surrounding mucosa or slightly
elevated due to edema; the mucosa
is undermined at the edges
Radiating mucosal rugae
80% are solitary, 80% occur in the
duodenum, of which 90% in the
first part of the duodenum on the
anterior wall’ within a few
centimeter of the pyloric ring.
19% occur in the stomach(usually at
the lesser curvature at the border of
the body and antrum.
65
71. Microscopy:
Overhanging gastric
mucosal margins (A)
Necrotic fibrinoid
debris (B)
Acute inflammatory
infiltrate (C)
Granulation tissue
(D)
Fibrotic scarred
base (E)
71
A
B
C, D
E
72. Ulcer Base
Superficial thin layer of
necrotic fibrinoid debris
Zone of inflammatory
infiltrate with neutrophils
Zone of granulation
tissue with dilated blood
vessels and lymphocytes
Zone of fibrous scarring
72
74. Gastric ulcerDuodenal Ulcer
middle age 50-60Any age specially 30-40Age
More in maleMore in maleSex
SameStress job eg. ManagerOccupation
Epi. Can radiate to
back
Epigastric , discomfortPain
Immediately after
eating
2-3 hours after eating &
midnight
Onset
EatingHungerAgg.by
75. Gastric ulcerDuodenal Ulcer
Lying down or vomitingEatingRelived by
Few weeks1-2 monthsDuration
Common(to relieve the
pain)
UncommonVomiting
Pt. afraid to eatGoodAppetite
Avoid fried foodGood , eat to relieve the painDiet
wt. LossNo wt. lossWeight
60%40%Hematemesis
40%60%Melena
76. GASTRIC TUMORS
BENIGN:
POLYPS (HYPERPLASTIC vs. ADENOMATOUS)
LEIOMYOMAS (Same gross and micro as sm. muscle)
LIPOMAS (Same gross and micro as adipose tissue)
MALIGNANT
(ADENO)Carcinoma
LYMPHOMA
POTENTIALLY MALIGNANT
G.I.S.T. (Gastro-Intestinal “Stromal” Tumor)
CARCINOID (NEUROENDOCRINE)
79. GC is not far from us……
Napoleon‘s gastric cancer:tumor
found on the lesser curvature of
the stomach: What cause? How
to treat?
Ambition is never content, even on the
summit of greatness.
He conquered the larger part of Europe,
but he could not conquer gastric cancer
80. How to diagnose
What is epidemiology and etilogy
What is the pathology
How to treat
Content
81. How to diagnose
What is epidemiology and etilogy
What is the pathology
How to treat
Content
82. GC Worldwide incidence
Male 16.4
Female 8.2
Male 36.3
Female 16.9
Male 77.9
Female 33.3
Male 10.8
Female 4.9
Male 43.6
Female 19.0
Male 5.9
Female 2.6
Male 11.5
Female 4.3
Male 18.6
Female 13.3
Male 8.4
Female 4.0
Eastern
Europe
Japan
Australia/
New Zealand
China
Northern
Africa
Southern
Africa
Central
America
Western
Europe
North
America
In terms of geographic distribution, high
rates apply to Japan, China and Eastern
Europe and low rates to North America.
Almost 40% of cases occur in China .
Pazdur R et al. Cancer management: A multidisciplinary
approach. edition,2002
85. “The new study suggest he was
chronically infected with the
bacteria Helicobacter pylori.”
“full of salt-preserved foods but
sparse in fruits and vegetables--
common fare for long military”
H. pylori
Genetic factors
“his father had also died of
stomach cancer which led to
the theory that he had
inherited the disease.”
Diet
Precancerous
changes
Why Napoleon died of GC
chronic atrophic gastritis?
86. How to diagnose
What is epidemiology and etilogy
What is the pathology
How to treat
Content
87. Early gastric cancer
Defined as a tumor confined to the mucosal or submucosal
layer, with or without lymph node metastasis
89. Morphology
SITE - Favoured location is the
lesser curvature of the antropyloric region
Gastric carcinoma is classified on the basis of
- depth of invasion
- macroscopic growth pattern
- histologic subtype
91. Gross: Linitis
plastica carcinoma
diffusely infiltrates
the entire gastric
wall without forming
an intraluminal
mass. The wall of
the stomach is
typically thickened
to about 2-3 cm.
and has a leathery,
inelastic
consistency.
92. Lauren classification
Intestinal type
--- associated with most
environmental risk factors
--- carries a better prognosis
--- shows no familial history
Diffuse type
--- consists of scattered cell
clusters with poor prognosis
93. Intestinal type gland
formation by malignant
cells,
Gastric carcinoma.
Diffuse type demonstrating
signet-ring carcinoma cells.
94. Bormann classifications
Gross classification
phymatoid type
ulcerative type
infiltrative ulcerative
diffuse infiltrative type
96. TNM classification ——T
Primary tumor:
depth of tumor
invasion
Tx- cannot be assessed
T0- no evidence
Tis- carcinoma in situ, no invasion of
lamina
T1- invades lamina propria or
submucosa
T2- invades muscularis or subserosa
T3- penetrates serosa, no adjacent
structure
T4- invades adjacent structures
97. T:Primary tumor
Direct extension into omentum, pancreas,
diaphragm, transverse colon, and
duodenum.
If lesion extends beyond wall to a free
peritoneal surface, peritoneal involvement
is frequent.
98. TNM classification ——N
Regional Lymph Nodes
NX- cannot be assessed
N0- no nodes
N1- mets in 1-6 regional
nodes
N2- mets in 7-15 regional
nodes
N3- mets in more than 15
regional nodes
99. TNM classification ——M
Distant metastasis
MX- cannot be assessed
M0- no distant metastases
M1-distant metastases
101. Special term
Blumer shelf
A shelf palpable by reactal examination, due to
metastatic tumor cells gravitating from an abdominal
cancer and growing in the rectovesical or rectouterine
pouch
Krukenberg tumor
A tumor in the ovary by the spread of stomach cancer
102. What is the classification for Napoleon
,
GC
“The scientists suggest that Napoleon died
from a T3N1M0 (stage IIIA)
gastric cancer. This means the tumour (T3)
had spread to some local lymph nodes (N1)
near the stomach, but had not spread or
metastased (M0) to other organs. The
prognosis for such tumours is known to be
very poor. ”
103. How to diagnose
What is epidemiology and etilogy
What is the pathology
How to treat
Content
104. Clinical manifestation
Early Gastric Cancer
Asymptomatic or silent 80%
Peptic ulcer symptoms 10%
Nausea or vomiting 8%
Anorexia 8%
Early satiety 5%
Abdominal pain 2%
Gastrointestinal blood loss <2%
Weight loss <2%
Dysphagia <1%
105. Clinical manifestation
Advanced Gastric Cancer
Weight loss 60%
Abdominal pain 50%
Nausea or vomiting 30%
Anorexia 30%
Dysphagia 25%
Gastrointestinal blood loss 20%
Early satiety 20%
Peptic ulcer symptoms 20%
Abdominal mass or fullness 5%
Asymptomatic or silent <5%
106. Special signs
Linitis plastica:
--- diffusely infiltrating with a rigid stomach
Virchow’s node:
--- left supraclavicular lymph node
Sister Mary Joseph’s node:
--- umbilical lymph node
prerectal pouch mass (Blumer shelf)
--- seeding metastasis
108. Laboratory tests
Assists in determining optimal therapy.
CBC identifies anemia, with may be caused by bleeding,
liver dysfunction, or poor nutrition.
30% have anemia.
Tumor markers
CEA:carcino-embryonic antigen
CA19-9:carbohydrate antigen
CA724:carbohydrate antigen
109. Imaging Studies
Endoscopic diagnosis
--- biopsy needed for definitive diagnosis
Endoscopic screening
--- general population or high risk persons
110. How to diagnose Napoleon
,
GC
Endoscopic diagnosis?
Endoscopic Ultrasonography?
CT scan? Preoperative staging
......
Why?
111. How to diagnose
What is epidemiology and etilogy
What is the pathology
How to treat
Content
112. G.I.S.T. TUMORS
Can behave and/or look benign or malignant
Usually look like smooth muscle, i.e., “stroma”
Are usually POSITIVE for
c-KIT (CD117), i.e., express this antigen on immunochemical staining, the tumor cells are derived from the interstitial cells, of Cajal, a “neural”
type of cell
113. G.I.S.T. TUMORS
c-KIT (receptor for stem cell factor)
mutations
platelet-derived growth factor
receptor-a. (PDGFRA) mutations
tyrosine kinase inhibitor (STIS71) has
been shown to be effective in
treatment
115. CARCINOID TUMOR
arise from the diffuse components of the
endocrine system
majority are found in the GI tract, and more
than 40% occur in the small intestine
tracheobronchial tree and lungs
116. Gastric carcinoids
release peptide and nonpeptide
hormones to coordinate gut function
carcinoids are intramural or
submucosal masses that create small
polypoid lesions
120. The most important prognostic factor for GI carcinoid
tumors is location
Foregut carcinoid tumors
rarely metastasize and are generally cured by resection
Midgut carcinoid tumors
Aggressive, greater depth of local invasion, increased size, and presence of
necrosis and mitosis are associated with poor outcome
Hindgut carcinoids occur in appendix & rectum
in appendix almost uniformly benign < 2cm
Rectal carcinoid rarely metastsize
121. GASTRIC LYMPHOMA
Primary :
Mucosa (gut)-associated lymphoid tissue tumor
Previously called
MALToma, MALT-type lymphoma, or MALT lymphoma,
Now called
Extranodal marginal zone B-cell lymphoma of MALT type
lymphoepithelial lesion (LEL) is a hallmark
Secondary
spread from adjacent lymph nodes